BamSEC and AlphaSense Join Forces
Learn More

Entero Therapeutics Inc.

NASDAQ: ENTO    
Share price (1/8/25): $0.62    
Market cap (1/8/25): $2.947 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from S-1/A 15 pages Placement Agency Agreement
12/34/56
EX-1.1
from S-1/A 17 pages Placement Agency Agreement [ ], 2023
12/34/56
EX-1.1
from 8-K 49 pages AzurRx Biopharma, Inc. 9,090,910 Shares of Common Stock (Par Value $0.0001 Per Share) Amended and Restated Underwriting Agreement
12/34/56
EX-1.2
from S-3 37 pages At the Market Offering Agreement May 26, 2021
12/34/56
EX-1.1
from 8-K 31 pages 5,000,000 Shares AzurRx Biopharma, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 29 pages 4,160,000 Shares AzurRx Biopharma, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 56 pages Underwriting Agreement Among AzurRx Biopharma, Inc. and Wallachbeth Capital, LLC and Network 1 Financial Securities, Inc., as Representatives of the Several Underwriters -1- AzurRx Biopharma, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 48 pages Underwriting Agreement Among AzurRx Biopharma, Inc. and Wallachbeth Capital, LLC and Network 1 Financial Securities, Inc., as Representatives of the Several Underwriters AzurRx Biopharma, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 51 pages Underwriting Agreement Among AzurRx Biopharma, Inc. and Wallachbeth Capital, LLC and Network 1 Financial Securities, Inc., as Representatives of the Several Underwriters AzurRx Biopharma, Inc. Underwriting Agreement
12/34/56
EX-1.1
from DRS/A 45 pages Underwriting Agreement Between AzurRx Biopharma, Inc. and Alexander Capital, L.P., as Representative of the Several Underwriters AzurRx Biopharma, Inc. Underwriting Agreement
12/34/56